203 related articles for article (PubMed ID: 37113570)
1. Efficacy and safety of selegiline for the treatment of Parkinson's disease: A systematic review and meta-analysis.
Wang K; Liu ZH; Li XY; Li YF; Li JR; Hui JJ; Li JX; Zhou JW; Yi ZM
Front Aging Neurosci; 2023; 15():1134472. PubMed ID: 37113570
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Comparison of selegiline and levodopa combination therapy versus levodopa monotherapy in the treatment of Parkinson's disease: a meta-analysis.
Jiang DQ; Li MX; Jiang LL; Chen XB; Zhou XW
Aging Clin Exp Res; 2020 May; 32(5):769-779. PubMed ID: 31175606
[TBL] [Abstract][Full Text] [Related]
4. Acupuncture-Related Therapies for Parkinson's Disease: A Meta-Analysis and Qualitative Review.
Wen X; Li K; Wen H; Wang Q; Wu Z; Yao X; Jiao B; Sun P; Ge S; Wen C; Lu L
Front Aging Neurosci; 2021; 13():676827. PubMed ID: 34276340
[No Abstract] [Full Text] [Related]
5. Rotigotine in Combination with the MAO-B Inhibitor Selegiline in Early Parkinson's Disease: A Post Hoc Analysis.
Giladi N; Asgharnejad M; Bauer L; Grieger F; Boroojerdi B
J Parkinsons Dis; 2016 Apr; 6(2):401-11. PubMed ID: 27061066
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of therapeutic massage for improving motor symptoms in Parkinson's disease: A systematic review and meta-analysis.
Kang Z; Xing H; Lin Q; Meng F; Gong L
Front Neurol; 2022; 13():915232. PubMed ID: 36133798
[TBL] [Abstract][Full Text] [Related]
7. Comparative efficacy of selegiline versus rasagiline in the treatment of early Parkinson's disease.
Marconi S; Zwingers T
Eur Rev Med Pharmacol Sci; 2014 Jul; 18(13):1879-82. PubMed ID: 25010617
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of aerobic and resistance training on the motor symptoms in Parkinson's disease: Systematic review and network meta-analysis.
Zhou X; Zhao P; Guo X; Wang J; Wang R
Front Aging Neurosci; 2022; 14():935176. PubMed ID: 35978948
[TBL] [Abstract][Full Text] [Related]
9. Potential use of glutathione as a treatment for Parkinson's disease.
Wang HL; Zhang J; Li YP; Dong L; Chen YZ
Exp Ther Med; 2021 Feb; 21(2):125. PubMed ID: 33376507
[TBL] [Abstract][Full Text] [Related]
10. Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.
Rolinski M; Fox C; Maidment I; McShane R
Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD006504. PubMed ID: 22419314
[TBL] [Abstract][Full Text] [Related]
11. Comparative efficacy and safety of monoamine oxidase type B inhibitors plus channel blockers and monoamine oxidase type B inhibitors as adjuvant therapy to levodopa in the treatment of Parkinson's disease: a network meta-analysis of randomized controlled trials.
Yan R; Cai H; Cui Y; Su D; Cai G; Lin F; Feng T
Eur J Neurol; 2023 Apr; 30(4):1118-1134. PubMed ID: 36437702
[TBL] [Abstract][Full Text] [Related]
12. Zishen pingchan granules combined with pramipexole in the improvement of depressive symptoms in Parkinson's disease: a prospective, multicenter, randomized, double-blind, controlled clinical study.
Ning H; Zhou H; Ren J; Zhou G; Yang N; Wang Z; Yuan C; Tian Z; Chen J; Shen L; Zheng H; Zhao Y; Wang H; Liu W; Liu Z
J Transl Med; 2022 Aug; 20(1):357. PubMed ID: 35962349
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of abdominal acupuncture in Parkinson's disease: A protocol for systematic review and meta-analysis.
Fang Y; Xu Y; Liu Z; Dong S; Su Y
Medicine (Baltimore); 2022 Nov; 101(47):e31804. PubMed ID: 36451468
[TBL] [Abstract][Full Text] [Related]
14. Rasagiline as Adjunct to Levodopa for Treatment of Parkinson's Disease: A Systematic Review and Meta-Analysis.
Kano O; Tsuda H; Hayashi A; Arai M
Parkinsons Dis; 2022; 2022():4216452. PubMed ID: 36081594
[TBL] [Abstract][Full Text] [Related]
15. Accumulation of
Murakami H; Nohara T; Uchiyama M; Owan Y; Futamura A; Shiromaru A; Tsukada S; Saito Y; Kuroda T; Yano S; Ishigaki S; Katoh H; Munechika J; Ohgiya Y; Gokan T; Ono K
Front Aging Neurosci; 2017; 9():321. PubMed ID: 29033831
[No Abstract] [Full Text] [Related]
16. A multiple treatment comparison meta-analysis of monoamine oxidase type B inhibitors for Parkinson's disease.
Binde CD; Tvete IF; Gåsemyr J; Natvig B; Klemp M
Br J Clin Pharmacol; 2018 Sep; 84(9):1917-1927. PubMed ID: 29847694
[TBL] [Abstract][Full Text] [Related]
17. Herbal Medicine Formulas for Parkinson's Disease: A Systematic Review and Meta-Analysis of Randomized Double-Blind Placebo-Controlled Clinical Trials.
Shan CS; Zhang HF; Xu QQ; Shi YH; Wang Y; Li Y; Lin Y; Zheng GQ
Front Aging Neurosci; 2018; 10():349. PubMed ID: 30467472
[No Abstract] [Full Text] [Related]
18. Ropinirole versus bromocriptine in the treatment of early Parkinson's disease: a 6-month interim report of a 3-year study. 053 Study Group.
Korczyn AD; Brooks DJ; Brunt ER; Poewe WH; Rascol O; Stocchi F
Mov Disord; 1998 Jan; 13(1):46-51. PubMed ID: 9452325
[TBL] [Abstract][Full Text] [Related]
19. Selegiline for Alzheimer's disease.
Birks J; Flicker L
Cochrane Database Syst Rev; 2003; (1):CD000442. PubMed ID: 12535396
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Selegiline Monotherapy for the Treatment of Early Parkinson Disease.
Mizuno Y; Hattori N; Kondo T; Nomoto M; Origasa H; Takahashi R; Yamamoto M; Yanagisawa N
Clin Neuropharmacol; 2019; 42(4):123-130. PubMed ID: 31045589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
